Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

vaccination-1215279_960_720

Rise in populism linked to vaccine hesitancy in Europe, study shows

February 26, 2019 Manufacturing and Production EU, Europe, populism, populist parties, vaccine hesitancy, vaccines

Parent’s reluctance to vaccinate their children correlates with the number of people voting for populist parties, according to a study …
News

Living with melanoma after surgery

February 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, melanoma, patient experience, pharma

Dr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
News
040424_026_avonmouth

Avara Avlon falls into administration putting 270 Bristol jobs at risk

February 21, 2019 Manufacturing and Production AstraZeneca, Avara Avlon, Bristol, CDMO, Jobs, UK, manufacturing

Bristol-based pharma firm Avara Avlon Pharmaceuticals has fallen into administration putting the jobs of all 270 of its staff at …
News

Philippines’ FDA halts sales of Sanofi’s dengue vaccine

February 19, 2019 Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …
News
bacteria-163711_960_720

San Francisco scientists use CRISPR to develop stem cells invisible to the immune system

February 19, 2019 Manufacturing and Production Nature Biotechnology, Stem cells, UC San Francisco, iPSCs, regenerative medicine

Scientists at UC San Francisco have used the gene editing tool CRISPR Cas9 to manufacture pluripotent stem cells (stem cells …
News
shutterstock_244903099

“Game-changing” osteoarthritis drug receives £675k funding from Innovate UK

February 19, 2019 Manufacturing and Production, Research and Development AKL Research and Development, Innovate UK, osteoarthritis, pharma

A novel and potentially “game-changing” oral therapy for the treatment of osteoarthritis (OA) has received a £675,000 cash injection from …
News
chinese_flag_beijing_-_img_1104

China to establish national rare disease network

February 19, 2019 Manufacturing and Production China, NHC, healthcare, rare diseases

China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early …
News

Japanese researchers to trial stem cell therapy in four patients with serious spinal injuries

February 19, 2019 Manufacturing and Production Japan, Keio University, Parkinson's, cell therapy, iPS

The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …
News
screen_shot_2019-01-29_at_15

Beating the flu

February 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus

On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMR, Dame Sally Davies, FDA, FMD, antibiotic resistance, esketamine, falsified medicines, top 10

News that the FDA’s advisory panel had recommended Janssen’s intranasal esketamine spray Spravato as a treatment for treatment resistant depression, …
News

J&J acquires lung cancer-focused robotics firm Auris Health in potential $5.75m deal

February 14, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Auris Health, Cancer, J&J, JJ, lung cancer, pharma, robotics

In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics …
News
dr_nathwani_770x510

Sanofi name current CMO Dr Ameet Nathwani as new Chief Digital Officer

February 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French firm Sanofi has appointed pharma veteran Dr Ameet Nathwani to the position of Chief Digital Officer. In his new …
Appointment
scotland

Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland

February 12, 2019 Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma

It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …
News
guernsey-1881254_960_720

Immuno Biotech financial chief found guilty of money laundering

February 12, 2019 Manufacturing and Production David Noakes, Dawson-Ball, GcMAF, Guernsey, Immuno Biotech

Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm immuno Biotech, that sold unlicensed blood product GcMAF, has been …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026